Polyphron
6 employees on LinkedIn · 3 known investors
Find your way into Polyphron
Sign up to see every warm intro you have to Polyphron
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Polyphron team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Polyphron is using AI and automation to produce human tissue at scale, providing ground-truth data for AI biology and developing therapeutics based on immune-compatible iPSC-derived grafts.
Founders & leadership
FB

Fabio BonioloCSO & CofounderFounder of Polyphron, which uses AI and automation to produce human tissue at scale for research and therapeutic applications.
Investors · 3
Compoundlisted by CompoundNew York · $400K – $1.5M
How we know: Compound's portfolio page · the VCSheet dataset · Not right? Tell us
Fifty Yearslisted by Fifty YearsSan Francisco · $250K – $2M
How we know: Fifty Years's portfolio page · Not right? Tell us
Humba Ventureslisted by Humba VenturesSan Francisco · $750K – $1.5M
How we know: Humba Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 1
Companies working in the same space as Polyphron.
Frequently asked questions
- What does Polyphron do?
- Polyphron is using AI and automation to produce human tissue at scale, providing ground-truth data for AI biology and developing therapeutics based on immune-compatible iPSC-derived grafts.
- Who founded Polyphron?
- Polyphron was founded by Fabio Boniolo.
- Who are Polyphron's investors?
- Polyphron's investors include Compound, Fifty Years, Humba Ventures.


.jpeg)